Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Trial to Evaluate the Safety, Immunogenicity, and Non-Interference With Concomitant Routine Vaccines, of a Meningococcal Serogroup ACYWX Conjugate Vaccine (NmCV-5) in Comparison With MenACWY-TT Conjugate Vaccine in Healthy Malian Infants

NCT05093829 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT05093829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05093829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Trial to Evaluate the Safety, Immunogenicity, and Non-Interference With Concomitant Routine Vaccines, of a Meningococcal Serogroup ACYWX Conjugate Vaccine (NmCV-5) in Comparison With MenACWY-TT Conjugate Vaccine in Healthy Malian Infants
Lead sponsor
Emory University
Phase
Phase 3
Overall status
Completed
Start date
March 24, 2022
Completion date
February 20, 2025
Enrollment
1,325 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

meningitis